TrialNature communications2024

The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers.

Meriem Messaoudene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.